Yixing Jiang

Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study

James J. Harding, Jia Fan, Do‐Youn Oh et al. · The Lancet Oncology · 2023 · 247 citations · Full text

Medicine, Oncology, Pharmacology +10

c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma

Hanning You, Wei Ding, Hien Dang et al. · Hepatology · 2011 · 186 citations · Full text

Medicine, Oncology, Pharmacology +17

Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer

Jun Zhang, Yixing Jiang, Zhiliang Jia et al. · Clinical & Experimental Metastasis · 2006 · 184 citations

Medicine, Cancer Biology, Oncology +17

Phase III study of maintenance gemcitabine (G) and best supportive care (BSC) versus BSC, following standard combination therapy with gemcitabine-carboplatin (G-Cb) for patients with advanced non-small cell lung cancer (NSCLC).

Chandra P. Belani, David Waterhouse, Hassan Ghazal et al. · Journal of Clinical Oncology · 2010 · 99 citations

Medicine, Oncology, Pharmacology +17

Stat3 Plays an Important Role in Oncogenic Ros- and Insulin-like Growth Factor I Receptor-induced Anchorage-independent Growth

Cong S. Zong, Liyu Zeng, Yixing Jiang et al. · Journal of Biological Chemistry · 1998 · 91 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16